Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb
Open Access
- 12 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2) , e56553
Abstract
IUGR increases the risk of type 2 diabetes mellitus (T2DM) in later life, due to reduced insulin sensitivity and impaired adaptation of insulin secretion. In IUGR rats, development of T2DM can be prevented by neonatal administration of the GLP-1 analogue exendin-4. We therefore investigated effects of neonatal exendin-4 administration on insulin action and β-cell mass and function in the IUGR neonate in the sheep, a species with a more developed pancreas at birth. Twin IUGR lambs were injected s.c. daily with vehicle (IUGR+Veh, n = 8) or exendin-4 (1 nmol.kg-1, IUGR+Ex-4, n = 8), and singleton control lambs were injected with vehicle (CON, n = 7), from d 1 to 16 of age. Glucose-stimulated insulin secretion and insulin sensitivity were measured in vivo during treatment (d 12–14). Body composition, β-cell mass and in vitro insulin secretion of isolated pancreatic islets were measured at d 16. IUGR+Veh did not alter in vivo insulin secretion or insulin sensitivity or β-cell mass, but increased glucose-stimulated insulin secretion in vitro. Exendin-4 treatment of the IUGR lamb impaired glucose tolerance in vivo, reflecting reduced insulin sensitivity, and normalised glucose-stimulated insulin secretion in vitro. Exendin-4 also reduced neonatal growth and visceral fat accumulation in IUGR lambs, known risk factors for later T2DM. Neonatal exendin-4 induces changes in IUGR lambs that might improve later insulin action. Whether these effects of exendin-4 lead to improved insulin action in adult life after IUGR in the sheep, as in the PR rat, requires further investigation.Keywords
This publication has 77 references indexed in Scilit:
- Exenatide as a Weight‐Loss Therapy in Extreme Pediatric Obesity: A Randomized, Controlled Pilot StudyObesity, 2012
- Brain GLP-1 Signaling Regulates Femoral Artery Blood Flow and Insulin Sensitivity Through Hypothalamic PKC-δDiabetes, 2011
- The transition from fetal growth restriction to accelerated postnatal growth: a potential role for insulin signalling in skeletal muscleThe Journal of Physiology, 2009
- Adipose Tissue Plasticity During Catch-Up Fat Driven by Thrifty MetabolismDiabetes, 2009
- Perinatal Risk Factors for Diabetes in Later LifeDiabetes, 2009
- Brain Glucagon-Like Peptide-1 Regulates Arterial Blood Flow, Heart Rate, and Insulin SensitivityDiabetes, 2008
- Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1Journal of Clinical Investigation, 2008
- Physiological development of insulin secretion, calcium channels, and GLUT2 expression of pancreatic rat β-cellsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasisAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Ontogenic development of peptide hormones in the mammalian fetal pancreasCellular and Molecular Life Sciences, 1988